Does Dr. B. PATRICK BAGHDIKIAN have financial conflicts of interest?

Dr. B. PATRICK BAGHDIKIAN (MD) has received a total of $137 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $137 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. B. PATRICK BAGHDIKIAN?

According to CMS Open Payments data, Dr. B. PATRICK BAGHDIKIAN received funding from STRYKER CORPORATION ($62), DEPUY SYNTHES SALES ($41), and VERTEX PHARMACEUTICALS INCORPORATED ($33).

Does Dr. B. PATRICK BAGHDIKIAN receive research grants or speaking fees?

Dr. B. PATRICK BAGHDIKIAN has received $137 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. B. PATRICK BAGHDIKIAN

MDReal-Time Hydrated

Specialty: Anesthesiology

Practice Location: SOUTH LAKE TAHOE, CA 96150

NPI Number: 1053417303

LIFETIME INDUSTRY VALUE

$137

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BAGHDIKIAN is a verified Anesthesiology practitioner based in SOUTH LAKE TAHOE, CA.

Between 2021 and 2024, Dr. BAGHDIKIAN had an overall industry promotional and research financial footprint of $137 as recorded in the federal CMS Open Payments database.

$137 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BAGHDIKIAN's primary funding source is STRYKER CORPORATION, which accounts for $62 (representing 45.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

STRYKER CORPORATION

Rank 1

$62

45.5%

DEPUY SYNTHES SALES

Rank 2

$41

30.2%

VERTEX PHARMACEUTICALS INCORPORATED

Rank 3

$33

24.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.